Showing results (691-700 of 1,157) with videos related to
Sort By:
Pageof 116
British Journal of Pharmacology|February 13, 2001
Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferensR A Ross, T M Gibson, H C Brockie, et al.Journal of Neurochemistry|March 29, 2000
Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant ratsV Di Marzo, F Berrendero, T Bisogno, et al.British Journal of Pharmacology|May 19, 2012
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanismsLuciano De Petrocellis, Alessia Ligresti, Aniello Schiano Moriello, et al.Drug and Alcohol Dependence|April 22, 2004
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinenceSara González, Javier Fernández-Ruiz, Vincenzo Di Marzo, et al.Journal of Neurophysiology|March 20, 2009
Functional interaction between TRPV1 and mu-opioid receptors in the descending antinociceptive pathway activates glutamate transmission and induces analgesiaSabatino Maione, Katarzyna Starowicz, Luigia Cristino, et al.British Journal of Pharmacology|September 11, 2014
Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agentFrancesca Borrelli, Barbara Romano, Stefania Petrosino, et al.Journal of Lipid Research|May 27, 2026
Intestinal colonization of germ-free mice with indole-producing E. coli modulates the central and peripheral endocannabinoidomeGiada Giorgini, Hayatte-Dounia Mir, Camille Etienne, et al.CNS & Neurological Disorders Drug Targets|April 14, 2016
Chalcone Derivatives Activate and Desensitize the Transient Receptor Potential Ankyrin 1 Cation Channel, Subfamily A, Member 1 TRPA1 Ion Channel: Structure-Activity Relationships in vitro and Anti-Nociceptive and Anti-inflammatory Activity in vivoAniello Schiano Moriello, Livio Luongo, Francesca Guida, et al.Frontiers in Synaptic Neuroscience|February 22, 2021
Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese MiceLea Tunisi, Livia D'Angelo, Alba Clara Fernández-Rilo, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 9, 2005
Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosisSilvia Ortega-Gutiérrez, Eduardo Molina-Holgado, Angel Arévalo-Martín, et al.Pageof 116